A combined immune and exosome-related risk signature as prognostic biomakers in acute myeloid leukemia

CONCLUSIONS: An immune-ERG-based risk model was developed to effectively predict prognostic outcomes for AML patients. There is potential for immune therapy in AML targeting the five hub genes.PMID:38186215 | DOI:10.1080/16078454.2023.2300855

Source: Hematology - January 8, 2024 Category: Hematology Authors: Zenghui Fang Jiali Fu Xin Chen Source Type: research